Feature Channels: Cell Biology

Filters close
Newswise: UT Southwestern immunologists uncover obesity-linked trigger to severe form of liver disease
Released: 27-Dec-2022 9:00 AM EST
UT Southwestern immunologists uncover obesity-linked trigger to severe form of liver disease
UT Southwestern Medical Center

UT Southwestern immunologists have uncovered a key pathogenic event prompted by obesity that can trigger severe forms of nonalcoholic fatty liver disease and potential liver failure.

Released: 22-Dec-2022 7:35 PM EST
New sensor uses MRI to detect light deep in the brain
Massachusetts Institute of Technology (MIT)

Using a specialized MRI sensor, MIT researchers have shown that they can detect light deep within tissues such as the brain.

   
Newswise: Ultrafast and ultra-sensitive protein detection method allows for ultra-early disease diagnoses
Released: 22-Dec-2022 6:55 PM EST
Ultrafast and ultra-sensitive protein detection method allows for ultra-early disease diagnoses
Osaka City University

Protein detection based on antigen–antibody reaction is vital in early diagnosis of a wide range of diseases. How to effectively detect proteins, however, has frequently bedeviled researchers.

   
Newswise: Rewriting the Textbook on Gene Regulation: It’s the Big Picture That Counts
Released: 22-Dec-2022 11:05 AM EST
Rewriting the Textbook on Gene Regulation: It’s the Big Picture That Counts
University of California San Diego

For the first time, researchers at UC San Diego have shown that changes in gene expression happen almost entirely during the transcription stage while the cells are growing. The researchers have provided a simple quantitative formula linking regulatory control to mRNA and protein levels.

Newswise: Found! Lost Puzzle Piece Involved in Gene Regulation Revealed in Search That Began in Water-Loving, One-Celled Organism
Released: 22-Dec-2022 10:00 AM EST
Found! Lost Puzzle Piece Involved in Gene Regulation Revealed in Search That Began in Water-Loving, One-Celled Organism
Johns Hopkins Medicine

After an intrepid, decade-long search, Johns Hopkins Medicine scientists say they have found a new role for a pair of enzymes that regulate genome function and, when missing or mutated, are linked to diseases such as brain tumors, blood cancers and Kleefstra syndrome — a rare genetic, neurocognitive disorder.

Newswise: Sotorasib shows clinically meaningful activity in KRAS G12C-mutated advanced pancreatic cancer
21-Dec-2022 12:55 PM EST
Sotorasib shows clinically meaningful activity in KRAS G12C-mutated advanced pancreatic cancer
University of Texas MD Anderson Cancer Center

In the Phase I/II CodeBreaK 100 trial, the KRAS G12C inhibitor sotorasib achieved meaningful anticancer activity with an acceptable safety profile in heavily pretreated patients with KRAS G12C-mutated metastatic pancreatic cancer, according to researchers at The University of Texas MD Anderson Cancer Center.

Newswise: How nerve and vascular cells coordinate their growth
Released: 21-Dec-2022 4:45 PM EST
How nerve and vascular cells coordinate their growth
University of Bonn

Nerve cells need a lot of energy and oxygen. They receive both through the blood. This is why nerve tissue is usually crisscrossed by a large number of blood vessels.

   
16-Dec-2022 5:30 PM EST
Stem Cell Transplants May Delay Disability Longer than Some MS Medications
American Academy of Neurology (AAN)

In people with active secondary progressive multiple sclerosis (MS), hematopoietic stem cell transplants may delay disability longer than some other MS medications, according to a study published in the December 21, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study involved autologous hematopoietic stem cell transplants, which use healthy blood stem cells from a person’s own body to replace diseased cells.

Released: 21-Dec-2022 12:50 PM EST
UC Irvine-led study links metabolism changes in certain brain cells to Huntington’s disease
University of California, Irvine

Irvine, Calif., Dec. 21, 2022 — A research team led by the University of California, Irvine has linked the mutation that causes Huntington’s disease to developmental deficits in the brain’s oligodendrocyte cells that are caused by changes in metabolism. They found that high doses of thiamine and biotin can restore normal processes.

Newswise: Decoding the secret language of photosynthesis
Released: 21-Dec-2022 12:15 PM EST
Decoding the secret language of photosynthesis
University of California, Riverside

For decades, scientists have been stumped by the signals plants send themselves to initiate photosynthesis, the process of turning sunlight into sugars. UC Riverside researchers have now decoded those previously opaque signals.

Newswise: Shedding light on the origin of complex life forms
Released: 21-Dec-2022 11:00 AM EST
Shedding light on the origin of complex life forms
University of Vienna

How did the complex organisms on Earth arise? This is one of the big open questions in biology. A collaboration between the working groups of Christa Schleper at the University of Vienna and Martin Pilhofer at ETH Zurich has come a step closer to the answer. The researchers succeeded in cultivating a special archaeon and characterizing it more precisely using microscopic methods.

Released: 21-Dec-2022 10:55 AM EST
CHOP and NJIT Researchers Develop New Tool for Studying Multiple Characteristics of a Single Cell
Children's Hospital of Philadelphia

Researchers from Children’s Hospital of Philadelphia (CHOP) and New Jersey Institute of Technology (NJIT) developed new software that integrates a variety of information from a single cell, allowing researchers to see how one change in a cell can lead to several others and providing important clues for pinpointing the exact causes of genetic-based diseases.

Newswise: Humans continue to evolve with the emergence of new genes
Released: 20-Dec-2022 8:05 PM EST
Humans continue to evolve with the emergence of new genes
Cell Press

Modern humans evolutionarily split from our chimpanzee ancestors nearly 7 million years ago, yet we are continuing to evolve.

   
Released: 20-Dec-2022 9:00 AM EST
Method Developed by Children’s Hospital Los Angeles Researchers Automates Brain Cell Mapping
Children's Hospital Los Angeles

Neuroscience graduate students at Children’s Hospital Los Angeles have developed an automated method that could save time and work for laboratories around the country by streamlining the process of identifying and mapping brain cells. Scientists want to understand how brain cells develop over time because the way these cells, called neurons, develop, influences how they function, or how they malfunction in neurodevelopmental disorders.

Newswise: Male wasps use genitalia to sting their predators
Released: 19-Dec-2022 3:45 PM EST
Male wasps use genitalia to sting their predators
Cell Press

Female bees and wasps use modified ovipositors, formerly used in egg laying, to sting their attackers, including people.

Newswise: Why Don’t T Cells Destroy Solid Tumors during Immunotherapy?
Released: 19-Dec-2022 3:05 PM EST
Why Don’t T Cells Destroy Solid Tumors during Immunotherapy?
University of North Carolina School of Medicine

Jessica Thaxton’s group at the UNC School of Medicine found that T cells exposed to the environment of solid cancers undergo a natural response to stress that shuts off their function, limiting T cell ability to kill tumors.

Newswise: The clever glue keeping the cell’s moving parts connected
Released: 19-Dec-2022 2:55 PM EST
The clever glue keeping the cell’s moving parts connected
Paul Scherrer Institute

Researchers from Paul Scherrer Institute PSI and ETH Zurich have discovered how proteins in the cell can form tiny liquid droplets that act as a smart molecular glue.

Released: 19-Dec-2022 1:35 PM EST
Paving the way for new drugs to treat a range of diseases
Argonne National Laboratory

Researchers from Boston Children’s Hospital and Harvard, using Argonne’s Advanced Photon Source, have characterized the structure of integrins, a type of cell surface receptor involved in the immune response.

Released: 19-Dec-2022 12:00 PM EST
MD Anderson Research Highlights for December 19, 2022
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. Current advances include a cell cycle checkpoint inhibitor with potential therapeutic effects in an ovarian cancer subtype, a telementoring program for French-speaking oncology providers in Africa, insights into the relationship between obesity and immunotherapy side effects, updates to the world’s largest cancer drug discovery knowledgebase, improvements to treatment response by blocking the EGFR pathway, and a novel noninvasive diagnostic test for immunotherapy-related kidney injury.

   
Newswise: The Donnan Potential, Revealed at Last
Released: 19-Dec-2022 11:00 AM EST
The Donnan Potential, Revealed at Last
Lawrence Berkeley National Laboratory

The Donnan electric potential arises from an imbalance of charges at the interface of a charged membrane and a liquid, and for more than a century it has stubbornly eluded direct measurement. Many researchers have even written off such a measurement as impossible. But that era, at last, has ended. With a tool that’s conventionally used to probe the chemical composition of materials, scientists at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) recently led the first direct measurement of the Donnan potential.

Newswise: Vanderbilt University Medical Center’s BioVU reaches milestone with biological samples
Released: 19-Dec-2022 9:40 AM EST
Vanderbilt University Medical Center’s BioVU reaches milestone with biological samples
Vanderbilt University Medical Center

BioVU, Vanderbilt University Medical Center’s biobank, has reached another milestone — deep-freeze storage of more than 300,000 biological samples.

Newswise: Scientists from NUS and NUHS identify predictive blood biomarker for cognitive impairment and dementia
Released: 19-Dec-2022 5:05 AM EST
Scientists from NUS and NUHS identify predictive blood biomarker for cognitive impairment and dementia
National University of Singapore (NUS)

A recent study by researchers from the NUS Yong Loo Lin School of Medicine and the Memory, Ageing and Cognition Centre under the National University Health System revealed that low levels of ergothioneine in blood plasma may predict an increased risk of cognitive impairment and dementia, suggesting possible therapeutic or early screening measures for cognitive impairment and dementia in the elderly.

Newswise: New targets in the fight against pancreatic cancer
Released: 15-Dec-2022 5:30 PM EST
New targets in the fight against pancreatic cancer
Tokyo Medical and Dental University

Pancreatic cancer remains one of the deadliest malignancies worldwide.

Released: 15-Dec-2022 5:20 PM EST
Octopuses may link evolution of complex life to genetic ‘dark matter’
Dartmouth College

Octopuses have captured the attention of scientists and the public with their remarkable intelligence, including the use of tools, engaging in creative play and problem-solving, and even escaping from aquariums.

   
Newswise: Looking for an Early Sign of LATE
Released: 15-Dec-2022 1:05 PM EST
Looking for an Early Sign of LATE
University of California San Diego

Researchers at UC San Diego provide new insights into the pathology of limbic predominate age-related TDP-43 encephalopathy, which mimics Alzheimer’s, making it very difficult to identify in living patients.

Newswise: Experts from 14 Nations Discuss Global Gene Drive Project Registry
15-Dec-2022 11:00 AM EST
Experts from 14 Nations Discuss Global Gene Drive Project Registry
University of California San Diego

UC San Diego Herbert Wertheim School of Public Health and Human Longevity Science led 70 participants from 14 nations in a discussion on the ways in which a gene drive project registry could both contribute to and detract from the fair development, testing and use of gene-drive modified organisms.

   
Released: 15-Dec-2022 10:05 AM EST
¿Qué es la terapia de células T con receptores quiméricos de antígenos?
Mayo Clinic

Se diagnosticaron aproximadamente 620 000 nuevos casos de linfoma en todo el mundo, según el informe del World Cancer Research Fund International de 2020. Las tasas de supervivencia han mejorado a medida que se desarrollan avances en el tratamiento, como la terapia de células T con receptores quiméricos de antígenos.

Released: 15-Dec-2022 9:05 AM EST
O que é a terapia de células T com receptor de antígeno quimérico?
Mayo Clinic

ROCHESTER, Minn.—Cerca de 620.000 novos casos de linfoma foram diagnosticados em todo o mundo, de acordo com o relatório do Fundo Mundial para Pesquisa em Câncer de 2020. As taxas de sobrevivência melhoraram à medida que se desenvolvem os avanços no tratamento, como a terapia de células T com receptor de antígeno quimérico.

Released: 15-Dec-2022 12:05 AM EST
什么是嵌合抗原受体-T细胞疗法?
Mayo Clinic

根据世界癌症研究基金会2020年的报告,全球在该年度新诊断出约620,000例淋巴瘤。随着在治疗手段上取得进步,例如嵌合抗原受体-T细胞疗法的推出,患者的存活率有所提升。

Released: 15-Dec-2022 12:05 AM EST
ما هو العلاج بالخلايا التائية ذات مستقبلات المستضدات الخميرية؟
Mayo Clinic

تم تشخيص ما يقرب من 620,000 ألف حالة جديدة باللمفومة في جميع أنحاء العالم، وفقًا لتقرير الصندوق العالمي لبحوث السرطان لعام 2020. وقد تحسنت معدلات النجاة مع تطور في العلاج، مثل: العلاج بالخلايا التائية ذات مستقبلات المستضدات الخيمرية.

Released: 14-Dec-2022 5:45 PM EST
From COVID-19 to the common cold: UBC scientists identify broadly-effective, infection-halting compound
University of British Columbia

Researchers at UBC’s Life Sciences Institute have identified a compound that shows early promise at halting infections from a range of coronaviruses, including all variants of SARS-CoV-2 and the common cold.

   
Newswise: Scientists identify multiple cell types that may contribute to treatment resistance in prostate cancer
Released: 13-Dec-2022 4:15 PM EST
Scientists identify multiple cell types that may contribute to treatment resistance in prostate cancer
eLife

Researchers have characterised prostate cancer cell dynamics at a single-cell resolution across the timespan of the disease – from its beginning to the point of androgen independence, where the tumour no longer responds to hormone deprivation therapy.

Released: 12-Dec-2022 6:25 PM EST
Report calls for improved oversight on chimeric human-animal research
Hastings Center

A new report on the ethics of crossing species boundaries by inserting human cells into nonhuman animals – research surrounded by debate – makes recommendations clarifying the ethical issues and calling for improved oversight of this work.

   
Newswise: CRISPR Technology Improves Huntington’s Disease Symptoms in Models
Released: 12-Dec-2022 1:10 PM EST
CRISPR Technology Improves Huntington’s Disease Symptoms in Models
University of California San Diego

Using models, researchers at UC San Diego School of Medicine, with colleagues elsewhere, describe using RNA-targeting CRISPR/Cas13d technology to develop a new therapeutic strategy that specifically eliminates toxic RNA that causes Huntington’s Disease.

Released: 12-Dec-2022 1:05 PM EST
Unravelling the secrets of a good night's sleep
University of Tsukuba

A good night's sleep can work wonders for both mind and body. But what is it that determines how much we need to sleep, and what can cause us to sleep more deeply?

Newswise: Life and death of an
Released: 12-Dec-2022 6:00 AM EST
Life and death of an "altruistic" bacterium
Universite de Montreal

A new study led by Yves Brun shows how some bacteria living in a biofilm sacrifice themselves to ensure the survival of the community.

8-Dec-2022 1:55 PM EST
Experimental Cancer Therapy Shows Success in More Than 70 Percent of Patients in Global Clinical Trials
Mount Sinai Health System

A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73 percent of patients in two clinical trials, according to researchers from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.

10-Dec-2022 10:00 AM EST
Penn Medicine Researchers Present Advance in Re-Treatment with CAR T Therapy
Perelman School of Medicine at the University of Pennsylvania

Researchers from the University of Pennsylvania’s Abramson Cancer Center presented preliminary results of an ongoing Phase I clinical trial demonstrating successful re-treatment with CAR T cell therapy for patients whose cancers relapsed after previous CAR T therapy at the 2022 American Society of Hematology (ASH) Annual Meeting (Abstract 2016).

Newswise: New Computer Model Tracks Origin of Cell Changes That Drive Development
Released: 9-Dec-2022 5:05 PM EST
New Computer Model Tracks Origin of Cell Changes That Drive Development
Johns Hopkins Medicine

Scientists at Johns Hopkins Medicine say they have developed a computer model — dubbed quantitative fate mapping — that looks back in the developmental timeline to trace the origin of cells in a fully grown organism.

Released: 9-Dec-2022 4:50 PM EST
Aging is driven by unbalanced genes
Northwestern University

Northwestern University researchers have discovered a previously unknown mechanism that drives aging.

Released: 9-Dec-2022 10:00 AM EST
MD Anderson Research Highlights: ASH 2022 Special Edition
University of Texas MD Anderson Cancer Center

This special edition features presentations by MD Anderson researchers at the 2022 American Society of Hematology (ASH) Annual Meeting on innovative targeted therapies, new combination approaches and novel targets to improve outcomes for patients with leukemias, Hodgkin lymphoma, non-Hodgkin lymphoma, myeloma and other hematologic cancers.

Released: 9-Dec-2022 8:05 AM EST
“Phosphate marker” turned out to be important for regulation of protein, mutation of which causes leukemia
Scientific Project Lomonosov

Scientists showed that nucleolar protein nucleophosmin ( NPM1), the defection of which can cause the development of leukemia and other types of cancer, deals with its regulatory protein only by phosphorylation of nucleophosmin (including “phosphate marker” in its composition).

   
Released: 8-Dec-2022 6:50 PM EST
Developmental Lung Cell Atlas uncovers 144 cell states
Wellcome Trust Sanger Institute

The developing human lung has been mapped in unprecedented detail, identifying 144 cell states in the early stages of life, and uncovering new links between developmental cells and lung cancer.

Newswise:Video Embedded slacstanford-researchers-discover-how-a-nano-chamber-in-the-cell-directs-protein-folding
VIDEO
7-Dec-2022 12:45 PM EST
SLAC/Stanford researchers discover how a nano-chamber in the cell directs protein folding
SLAC National Accelerator Laboratory

A landmark study by researchers at the Department of Energy’s SLAC National Accelerator Laboratory and Stanford University reveals how a tiny cellular machine called TRiC directs the folding of tubulin, a human protein that is the building block of microtubules that serve as the cell’s scaffolding and transport system.

Released: 8-Dec-2022 10:05 AM EST
Dr. Nicolau Receives 2022 Development Grant from American Neuromuscular Foundation
American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)

The American Neuromuscular Foundation (ANF), is excited to announce the 2022 Development Grant Recipient, Stefan Nicolau, MD, for his research project “CRISPR/Cas9 correction of a common Duchenne muscular dystrophy (DMD) deletion.” Dr. Nicolau is a research fellow at the Abigail Wexner Research Institute at Nationwide Children’s Hospital in Columbus, OH.

   
Newswise:Video Embedded how-does-a-cell-move-pull-the-plug-on-the-electrical-charge-on-the-inner-side-of-its-membrane-say-scientists
VIDEO
Released: 8-Dec-2022 9:00 AM EST
How Does a Cell Move? ‘Pull the Plug’ on the Electrical Charge on the Inner Side of Its Membrane, Say Scientists
Johns Hopkins Medicine

Scientists at Johns Hopkins Medicine say that a key to cellular movement is to regulate the electrical charge on the interior side of the cell membrane, potentially paving the way for understanding cancer, immune cell and other types of cell motion. 

Released: 8-Dec-2022 5:05 AM EST
Promising small moleculars – dispiroalkanes exhibited high effectiveness against human cytomegalovirus
Scientific Project Lomonosov

Many pathogenic viruses, including herpesviruses, SARS -Cov-2, cytomegalovirus, papillomavirus, virus Nipah and others, use the similar mechanism to join the target cells, which consists in their attachment to heparan sulfate proteoglycan of the cell membrane.

Released: 7-Dec-2022 9:05 PM EST
Innovative treatment prevents development of diabetes
Babraham Institute

Researchers from the Liston lab, at the Babraham Institute, have recently published a preventative therapeutic for diabetes in mice.

Newswise: Evidence of autoimmunity’s origins uncovered via new approach
6-Dec-2022 6:20 PM EST
Evidence of autoimmunity’s origins uncovered via new approach
Washington University in St. Louis

Autoimmune diseases are thought to be the result of mistaken identity. Immune cells on patrol, armed and ready to defend the body against invading pathogens, mistake normal human cells for infected cells and turn their weapons on their own healthy tissues.

   


close
3.93584